Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway

Nature Communications

Volumn 7, Issue , 2016, Pages

  Ando, Fumiaki ^a   Sohara, Eisei ^a   Morimoto, Tetsuji ^b   Yui, Naofumi ^a   Nomura, Naohiro ^a   Kikuchi, Eriko ^a   Takahashi, Daiei ^a   Mori, Takayasu ^a   Vandewalle, Alain ^c   Rai, Tatemitsu ^a   Sasaki, Sei ^a   Kondo, Yoshiaki ^d   Uchida, Shinichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 2; ARACHIDONIC ACID; CALCINEURIN; CALCIUM; CALMODULIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; VASOPRESSIN; WNT5A PROTEIN; BETA CATENIN; DISHEVELLED PROTEIN; MESSENGER RNA; PHOSPHOSERINE; WATER; WNT5A PROTEIN, MOUSE;

CONCENTRATION (COMPOSITION); DIABETES; ENZYME ACTIVITY; GENE EXPRESSION; LIGAND; MEMBRANE; PROTEIN; URINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MOUSE; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; URINE OSMOLALITY; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CALCIUM SIGNALING; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; OSMOLARITY; PATHOLOGY; PERMEABILITY; PHOSPHORYLATION; URINE;

ANIMALS; AQUAPORIN 2; ARACHIDONIC ACID; BETA CATENIN; CALCINEURIN; CALCIUM; CALCIUM SIGNALING; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES INSIPIDUS, NEPHROGENIC; DISEASE MODELS, ANIMAL; DISHEVELLED PROTEINS; GENE EXPRESSION REGULATION; KIDNEY; MALE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; PERMEABILITY; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; WATER; WNT-5A PROTEIN;

EID: 84999085037     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13636     Document Type: Article

References (60)

1. Moeller, H. B., Rittig, S. & Fenton, R. A. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr. Rev. 34, 278-301 (2013).
2. Nakada, T., Miyauchi, T., Sumiya, H. & Shimazaki, J. Nonobstructive urinary tract dilatation in nephrogenic diabetes insipidus. Int. Urol. Nephrol. 22, 419-427 (1990).
3. Bichet, D. G. Nephrogenic diabetes insipidus. Adv. Chronic Kidney Dis. 13, 96-104 (2006).
4. Sasaki, S., Chiga, M., Kikuchi, E., Rai, T. & Uchida, S. Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2. Clin. Exp. Nephrol. 17, 338-344 (2013).
5. Olesen, E. T., Moeller, H. B., Assentoft, M., MacAulay, N. & Fenton, R. A. The vasopressin type-2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP independent pathway. Am. J. Physiol. Renal Physiol. 311, F935-F944 (2016).
6. Procino, G., Milano, S., Carmosino, M., Gerbino, A. & Bonfrate, L. Hereditary nephrogenic diabetes insipidus: molecular basis of the defect and potential novel strategies for treatment. J. Genet. Syndr. Gene Ther. 5, 2 (2014).
7. Li, J. H. et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J. Clin. Invest. 119, 3115-3126 (2009).
8. Bouley, R. et al. Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration. J. Am. Soc. Nephrol. 22, 59-72 (2011).
9. Olesen, E. T., Rützler, M. R., Moeller, H. B., Praetorius, H. A. & Fenton, R. A. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc. Natl Acad. Sci. USA 108, 12949-12954 (2011).
10. Procino, G. et al. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. Kidney Int. 86, 127-138 (2014).
11. Bouley, R. et al. Nitric oxide and atrial natriuretic factor stimulate cGMPdependent membrane insertion of aquaporin 2 in renal epithelial cells. J. Clin. Invest. 106, 1115-1126 (2000).
12. Li, W. et al. Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase. Am. J. Physiol. Renal Physiol. 301, F309-F318 (2011).
13. Procino, G. et al. Fluvastatin modulates renal water reabsorption in vivo through increased AQP2 availability at the apical plasma membrane of collecting duct cells. Pflugers Arch. 462, 753-766 (2011).
14. Nomura, N. et al. High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration. Am. J. Physiol. Cell Physiol. 307, C597-C605 (2014).
15. Hoffert, J. D., Chou, C. L., Fenton, R. A. & Knepper, M. A. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J. Biol. Chem. 280, 13624-13630 (2005).
16. Yip, K. P. Epac-mediated Ca(2+) mobilization and exocytosis in inner medullary collecting duct. Am. J. Physiol. Renal Physiol. 291, F882-F890 (2006).
17. De, A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim. Biophys. Sin. 43, 745-756 (2011).
18. Kremenevskaja, N. et al. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24, 2144-2154 (2005).
19. Dejmek, J., Säfholm, A., Kamp Nielsen, C., Andersson, T. & Leandersson, K. Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42- casein kinase 1alpha signaling in human mammary epithelial cells. Mol. Cell Biol. 26, 6024-6036 (2006).
20. Ma, L. & Wang, H. Y. Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca2+ pathway. J. Biol. Chem. 281, 30990-31001 (2006).
21. Säfholm, A. et al. A formylated hexapeptide ligand mimics the ability of Wnt- 5a to impair migration of human breast epithelial cells. J. Biol. Chem. 281, 2740-2749 (2006).
22. Person, A. D. et al. WNT5A mutations in patients with autosomal dominant Robinow syndrome. Dev. Dyn. 239, 327-337 (2010).
23. Oishi, I. et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645-654 (2003).
24. Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol. 204, 17-33 (2012).
25. Bens, M. et al. Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J. Am. Soc. Nephrol. 10, 923-934 (1999).
26. Hasler, U. et al. Long term regulation of aquaporin-2 expression in vasopressinresponsive renal collecting duct principal cells. J. Biol. Chem. 277, 10379-10386 (2002).
27. He, W. et al. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 20, 765-776 (2009).
28. Fushimi, K., Sasaki, S. & Marumo, F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J. Biol. Chem. 272, 14800-14804 (1997).
29. Tamma, G., Robben, J. H., Trimpert, C., Boone, M. & Deen, P. M. Regulation of AQP2 localization by S256 and S261 phosphorylation and ubiquitination. Am. J. Physiol. Cell Physiol. 300, C636-C646 (2011).
30. Hoffert, J. D. et al. Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. J. Biol. Chem. 283, 24617-24627 (2008).
31. Thrasivoulou, C., Millar, M. & Ahmed, A. Activation of intracellular calcium by multiple Wnt ligands and translocation of b-catenin into the nucleus: a convergent model of Wnt/Ca2+ and Wnt/b-catenin pathways. J. Biol. Chem. 288, 35651-35659 (2013).
32. Moeller, H. B., Knepper, M. A. & Fenton, R. A. Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells. Kidney Int. 75, 295-303 (2009).
33. Li, S. Z. et al. Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress. Am. J. Physiol. Cell Physiol. 292, C1606-C1616 (2007).
34. Brown, D., Hasler, U., Nunes, P., Bouley, R. & Lu, H. A. Phosphorylation events and the modulation of aquaporin 2 cell surface expression. Curr. Opin. Nephrol. Hypertens. 17, 491-498 (2008).
35. Rinschen, M. M. et al. Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. Proc. Natl Acad. Sci. USA 107, 3882-3887 (2010).
36. Ma, L. & Wang, H. Y. Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway. J. Biol. Chem. 282, 28980-28990 (2007).
37. Jung, H. J. et al. Tankyrase-mediated b-catenin activity regulates vasopressininduced AQP2 expression in kidney collecting duct mpkCCDc14 cells. Am. J. Physiol. Renal Physiol. 308, F473-F486 (2015).
38. Taurin, S., Sandbo, N., Qin, Y., Browning, D. & Dulin, N. O. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem. 281, 9971-9976 (2006).
39. Gon, H., Fumoto, K., Ku, Y., Matsumoto, S. & Kikuchi, A. Wnt5a signaling promotes apical and basolateral polarization of single epithelial cells. Mol. Biol. Cell 24, 3764-3774 (2013).
40. Yamamoto, H. et al. Basolateral secretion of Wnt5a in polarized epithelial cells is required for apical lumen formation. J. Cell Sci. 128, 1051-1063 (2015).
41. Lee, J. W., Chou, C. L. & Knepper, M. A. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J. Am. Soc. Nephrol. 26, 2669-2677 (2015).
42. Miranda, C. A., Lee, J. W., Chou, C. L. & Knepper, M. A. Tolvaptan as a tool in renal physiology. Am. J. Physiol. Renal Physiol. 306, F359-F366 (2014).
43. Kessen, U., Schaloske, R., Aichem, A. & Mutzel, R. Ca(2+)/calmodulinindependent activation of calcineurin from Dictyostelium by unsaturated long chain fatty acids. J. Biol. Chem. 274, 37821-37826 (1999).
44. Olesen, E. T. & Fenton, R. A. Is there a role for PGE2 in urinary concentration? J. Am. Soc. Nephrol. 24, 169-178 (2013).
45. Jo, I. et al. AQP2 is a substrate for endogenous PP2B activity within an inner medullary AKAP-signaling complex. Am. J. Physiol. Renal Physiol. 281, F958-F965 (2001).
46. Gooch, J. L., Pèrgola, P. E., Guler, R. L., Abboud, H. E. & Barnes, J. L. Differential expression of calcineurin A isoforms in the diabetic kidney. J. Am. Soc. Nephrol. 15, 1421-1429 (2004).
47. Gooch, J. L., Guler, R. L., Barnes, J. L. & Toro, J. J. Loss of calcineurin Aalpha results in altered trafficking of AQP2 and in nephrogenic diabetes insipidus. J. Cell Sci. 119, 2468-2476 (2006).
48. Moeller, H. B., Aroankins, T. S., Slengerik-Hansen, J., Pisitkun, T. & Fenton, R. A. Phosphorylation and ubiquitylation are opposing processes that regulate endocytosis of the water channel aquaporin-2. J. Cell Sci. 127, 3174-3183 (2014).
49. Lu, H. et al. Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP2. Am. J. Physiol. Renal Physiol. 286, F233-F243 (2004).
50. Rouch, A. J., Kudo, L. H. & Hébert, C. Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct. J. Pharmacol. Exp. Ther. 281, 62-69 (1997).
51. Pereira, C., Schaer, D. J., Bachli, E. B., Kurrer, M. O. & Schoedon, G. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler. Thromb. Vasc. Biol. 28, 504-510 (2008).
52. Catalán, V. et al. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation. J. Clin. Endocrinol. Metab. 99, E1407-E1417 (2014).
53. Wahba, I. M. & Mak, R. H. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2, 550-562 (2007).
54. Tanaka, K. et al. Imipramine, but not lithium, induces the serine/threonine phosphatase activity of calcineurin without affecting its mRNA expression in the rat brain. Psychopharmacology 162, 339-344 (2002).
55. Rushlow, W. J., Seah, Y. H., Belliveau, D. J. & Rajakumar, N. Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics. J. Neurochem. 94, 587-596 (2005).
56. Yang, S. S. et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab. 5, 331-344 (2007).
57. Mori, T. et al. Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy. Biochem. J. 455, 339-345 (2013).
58. Yui, N. et al. Basolateral targeting and microtubule-dependent transcytosis of the aquaporin-2 water channel. Am. J. Physiol. Cell Physiol. 304, C38-C48 (2013).
59. Quigley, R., Chakravarty, S. & Baum, M. Antidiuretic hormone resistance in the neonatal cortical collecting tubule is mediated in part by elevated phosphodiesterase activity. Am. J. Physiol. Renal Physiol. 286, F317-F322 (2004).
60. Schnermann, J. et al. Defective proximal tubular fluid reabsorption in transgenic aquaporin-1 null mice. Proc. Natl Acad. Sci. USA 95, 9660-9664 (1998).